Angelman syndrome is a rare neurodevelopmental disorder arising primarily from loss of function of the maternally inherited UBE3A gene. Research has shown that UBE3A plays a crucial role in neuronal ...
Mitch McKenny is unlikely to run again after spending four weeks running from Broken Hill to Newcastle, including the last ...
Angelman syndrome is a rare genetic, nondegenerative and neurodevelopmental disorder caused by mutations affecting the ...
TipRanks on MSN
Neuren Pharmaceuticals Receives FDA Fast Track for NNZ-2591 in Phelan-McDermid Syndrome
Neuren Pharmaceuticals Limited ( ($AU:NEU) ) just unveiled an update. Neuren Pharmaceuticals announced that the FDA has granted Fast Track ...
Investor's Business Daily on MSN
Why Ionis Stock Hit A Six-Year High And Snagged A Price-Target Hike
Ionis Pharmaceuticals guided to north of $5 billion in peak sales. Early Wednesday, Ionis stock hit a six-year high.
Treatment with setrusumab (UX143) for at least 6 months resulted in 67% reduction in annualized fracture rate in patients with OI in Phase 2/3 Orbit study Quantitative data from the Phase 1/2 study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback